Provided by Tiger Trade Technology Pte. Ltd.

Health Care Select Sector SPDR Fund

170.81
+2.651.58%
Post-market: 170.890.0812+0.05%19:47 EDT
Volume:7.05M
Turnover:1.20B
Market Cap:44.07B
PE:-12.01
High:171.04
Open:167.73
Low:167.52
Close:168.16
52wk High:176.60
52wk Low:141.05
Shares:258.02M
Float Shares:258.02M
Volume Ratio:0.84
T/O Rate:2.73%
Dividend:2.45
Dividend Rate:1.43%
EPS(TTM):-14.2170
EPS(LYR):-14.2170
ROE:-9.22%
ROA:1.03%
PB:1.28
PE(LYR):-12.01

Loading ...

Judge Denies In Part UnitedHealth's Motion to Dismiss CalPERS Suit

MT Newswires Live
·
Oct 01

Analysts Are Bullish on Top Healthcare Stocks: Jade Biosciences (JBIO), Liquidia Technologies (LQDA)

TIPRANKS
·
Oct 01

Judge Denies in Part UnitedHealth's Motion to Dismiss CalPERS Suit

MT Newswires Live
·
Oct 01

Analysts Offer Insights on Healthcare Companies: Q32 Bio (QTTB) and Wave Life Sciences (WVE)

TIPRANKS
·
Oct 01

Dow Drops 150 Points on Losses for Shares of Sherwin-Williams Co., Merck

Dow Jones
·
Oct 01

Exchange-Traded Funds Higher, US Equities Mixed After Midday

MT Newswires Live
·
Oct 01

Sector Update: Healthcare

MT Newswires Live
·
Oct 01

Lilly’s Clazakizumab Trial Pushes Cardiovascular Inflammation Strategy Forward

TIPRANKS
·
Oct 01

AbbVie Wraps Key Early Trial on ABBV-722 Drug Interaction, Supporting Pipeline Confidence

TIPRANKS
·
Oct 01

AbbVie’s Bretisilocin Study Completion Signals Quiet Progress in Early-Stage Pipeline

TIPRANKS
·
Oct 01

Health Care Roundup: Market Talk

Dow Jones
·
Oct 01

Autagco Signs Non-Binding MOU to Drive Healthcare and Wellness Expansion

TIPRANKS
·
Sep 30

Jefferies Remains a Buy on Humana (HUM)

TIPRANKS
·
Sep 30

Trump Pledges $500 Rebates to 1 Million Medicare Beneficiaries Each, to Be Mailed Starting Oct. 1

TradingKey
·
Sep 30

Analysts Offer Insights on Healthcare Companies: Kailera Therapeutics, Inc. (KLRA) and Immunome (IMNM)

TIPRANKS
·
Sep 30

Spyre Gains After Merck's Drug Succeeds in Skin Disease Trial

Reuters
·
Sep 30

Eli Lilly Reports 'Positive' Results From EloraTZP Trial

MT Newswires Live
·
Sep 30

Weight-Loss Drug Developers Line up to Tap Lucrative Market as Competition Heats Up

Reuters
·
Sep 30

Adding Lilly's New Drug to Zepbound Helped People Lose up to 23% of Their Weight. but There were More Side Effects.

Dow Jones
·
Sep 30

Eli Lilly Says EloraTZP Combo Delivered 'Substantial' Weight Loss, A1C Reduction in Phase 2b Trial

MT Newswires Live
·
Sep 30